Erythropoietin is approved for the treatment of anemia associated with renal failure, chemotherapy, preoperative anemia, and human immunodeficiency virus disease.
Savur
Sheila
S
Bonacini
Maurizio
M
Bzowej
Natalie
N
Gish
Robert
R
Wakil
Adil
A
Osorio
Robert
R
D000328:Adult; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications*; D016896:Treatment Outcome
D004921:Erythropoietin